UPDATE : Tuesday, September 25, 2018
상단여백
Bio-fever to continue as companies apply for KOSDAQ listing
The bio-fever in Korea's stock market will continue this year as more t...
by Lee Han-soo  |  2018-01-31 15:35
라인
Overheated DHP Korea stocks face short-term trade limit
DHP Korea, a manufacturer of eye drops and other ophthalmic agents, faced a...
by Nam Doo-hyun  |  2018-01-31 15:34
라인
Korean biosimilars expand global presence
Korean biosimilar drugs have begun to expand their presence in the global m...
by So Jae-hyeon  |  2018-01-31 11:51
라인
Medipost turns profitable after posting record sales
Medipost said Tuesday that it recorded 42.2 billion won ($39.3 million) in ...
by Lee Han-soo  |  2018-01-30 17:44
라인
Bridge Bio submits IND application for ulcerative colitis treatment
Bridge Biotherapeutics said Monday that it has submitted its first investig...
by Lee Han-soo  |  2018-01-29 13:42
라인
GC Lab Cell expects sales growth to continue
GC Lab Cell, a cell therapy developer, said Friday that it recorded 45.8 bi...
by Marian Chu  |  2018-01-26 18:23
라인
Competition heats up over Rituximab market share
The competition among pharmaceutical companies to carve out a larger share ...
by Lee Han-soo  |  2018-01-26 17:58
라인
Samsung Bioepis records robust earnings in the EU
The sales of Samsung Bioepis’ Benepali (Original: Enbrel) and Flixabi (Orig...
by Lee Han-soo  |  2018-01-26 14:03
라인
Patent applications for doping detection rise
Technologies used to detect doping are once again in the limelight as the 2...
by Marian Chu  |  2018-01-25 19:32
라인
GemVax & KAEL finds new implication for anticancer drug
GemVax & KAEL said Thursday that GV1001, also known as Riavax, has the pote...
by Lee Han-soo  |  2018-01-25 18:13
라인
Tech developed to detect diseases with single drop of fluid
Korean researchers have developed a new biosensor technology that can quick...
by Marian Chu  |  2018-01-25 12:00
라인
Analyst warns of possible ‘bubble’ amid bio-share surge
An analyst from Hana Financial Investment Corp. warned against a short-term...
by Lee Han-soo  |  2018-01-23 15:15
라인
Shares of ‘Celltrion trio’ plummet on profit-taking
Shares of Celltrion and its two affiliated firms plunged on Wednesday, and ...
by Nam Doo-hyun  |  2018-01-18 11:10
라인
Shares of eye drops/masks makers rise on fine dust measure
Shares of manufacturers of eye drops and masks have risen on Monday, with t...
by Nam Doo-hyun  |  2018-01-15 15:48
라인
Luxturna to open gene therapies market: analyst
The latest approval by the U.S. Food and Drug Administration for Luxturna, ...
by Nam Doo-hyun  |  2018-01-10 15:48
라인
Bio-shares on the rise
Bio-industry shares are on the rise amid expectations for favorable governm...
by Lee Han-soo  |  2018-01-09 15:26
라인
Celltrion’s market cap exceeds 36 trillion won
Celltrion has emerged as the fourth largest company by market capitalizatio...
by Lee Han-soo  |  2018-01-08 12:27
라인
Drugmakers rush to attend JP Morgan’s healthcare event
Many local pharmaceutical and biotech companies plan to attend J.P. Morgan’...
by So Jae-hyeon  |  2018-01-08 11:44
라인
Celltrion stocks jump on expectations of rising market share
Investors are paying attention to Celltrion, the local leader in the develo...
by Lee Han-soo  |  2018-01-04 16:40
라인
Venture capital investment in biomedical sector drops 20% in 2017
Venture capital investment in the local biomedical sector declined by 20 pe...
by Nam Doo-hyun  |  2018-01-04 09:30
여백
여백
여백
Back to Top